Skip to content
10-Q

Quarterly Report

MUSTANG BIO, INC. MBIO

0001104659-26-055598

← back to feed
Filed
May 5, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted Q1 2026 · Mar 31, 2026 6.73M sh
Shares Diluted Q1 2026 · Mar 31, 2025 2.86M sh
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$1.01M
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$1.39M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $16.26M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $17.27M
Stockholders Equity Q1 2026 · Mar 31, 2026 $8.6M
Stockholders Equity Q1 2026 · Dec 31, 2025 $9.53M
Stockholders Equity Q1 2026 · Mar 31, 2025 $3.61M
Stockholders Equity Q1 2026 · Dec 31, 2024 −$3.87M
Current Liabilities Q1 2026 · Mar 31, 2026 $7.84M
Current Liabilities Q1 2026 · Dec 31, 2025 $7.91M
Total Liabilities Q1 2026 · Mar 31, 2026 $7.99M
Total Liabilities Q1 2026 · Dec 31, 2025 $8.06M
Total Assets Q1 2026 · Mar 31, 2026 $16.58M
Total Assets Q1 2026 · Dec 31, 2025 $17.59M
Eps Diluted Q1 2026 · Mar 31, 2026 −$0.14
Eps Diluted Q1 2026 · Mar 31, 2025 −$0.05
Eps Basic Q1 2026 · Mar 31, 2026 −$0.14
Eps Basic Q1 2026 · Mar 31, 2025 −$0.05
Sga Expense Q1 2026 · Mar 31, 2026 $880K
Sga Expense Q1 2026 · Mar 31, 2025 $1.22M
Net Income Q1 2026 · Mar 31, 2026 −$955K
Net Income Q1 2026 · Mar 31, 2025 −$153K
Operating Income Q1 2026 · Mar 31, 2026 −$1.06M
Operating Income Q1 2026 · Mar 31, 2025 −$253K